Pupillometry
Diagnostic TestPupillar diameter variation measurement
NCT Number: NCT03823430
Pupillar diameter variation to predict success or failure of external ventricular derivation clamping.
Pupillometry utilisation as a diagnostic tool in external ventricular clamping test in neurological ICU should improve patients care in several ways :
* earlier use of ventriculo-peritoneal or ventriculo-atrial shunts to shorten the external ventricular treatment duration and thus reduce risks of infection and hospital stay duration * limit the medical imagery prescription and radiation exposition * avoid neurological deterioration linked to the external ventricular drain clamping in case of the pupillometric parameters variation would be earlier than clinical signs
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU Clermont Ferrand, Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pupillar diameter variation measurement
Time frame: 24 hours after clamping
Pupillar diameter variation twenty-four hours after external ventricular drain clamping
Association Pro-arte
Other
Acronym: CLAMP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05399602
Brain Damage, Brain Diseases
Hradec Králové, Czechia
View Trial DetailsNCT06083233
Biochemical Lesions Head Region, Brain Damage
Hradec Králové, Czechia
View Trial DetailsNCT04546737
Brain Damage, Brain Diseases
Amiens, France
View Trial DetailsNCT04288505
Brain Damage, Brain Diseases
Angers, France
View Trial Details